This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland
BOOK NOW
Menu
BOOK NOW

Dr. Monika Semmrich, PhD
Principal Scientist, Preclinical Research at BioInvent International AB
Speaker

Agenda Sessions

  • A Function-First Approach to Identify Regulatory T Cell-Targeting Antibodies for Immunotherapy

    , 09:20
    View Session

At this event

Prev
Next
Peter Senter, PhD
Co-Founder and CSO
Atida Bio

See Monika at Antibody Engineering & Therapeutics Europe

BOOK NOW